TABLE 4.
NC | SCD | F | interaction P-value | η2 | |||
|
|
||||||
Normal BMI (n = 29) |
High BMI (n = 17) |
Normal BMI (n = 38) |
High BMI (n = 27) |
||||
Fimbriaa | 140.02 ± 27.68 | 136.88 ± 42.62 | 140.71 ± 42.62 | 135.30 ± 30.08 | 0.468 | 0.496 | 0.005 |
Hippocampal taila | 1131.37 ± 148.57 | 1124.49 ± 145.31 | 1211.41 ± 145.31 | 1174.71 ± 150.21 | 4.077 | 0.046 | 0.040 |
Hippocampal fissurea | 311.08 ± 57.45 | 332.80 ± 43.91 | 313.00 ± 43.91 | 334.24 ± 61.54 | 0.085 | 0.771 | 0.001 |
Parasubiculuma | 118.63 ± 22.72 | 128.19 ± 39.14 | 125.66 ± 39.14 | 129.06 ± 26.69 | 0.565 | 0.454 | 0.006 |
HATAa | 372.18 ± 42.04 | 365.76 ± 61.01 | 385.50 ± 61.01 | 383.93 ± 47.42 | 0.356 | 0.552 | 0.004 |
Subiculuma | 875.96 ± 88.15 | 864.50 ± 108.60 | 900.03 ± 108.6 | 911.20 ± 99.37 | 0.002 | 0.961 | 0.000 |
Presubiculuma | 578.68 ± 61.11 | 587.29 ± 91.56 | 603.47 ± 91.56 | 599.56 ± 72.49 | 1.342 | 0.249 | 0.013 |
CA1a,b | 1261.17 ± 173.97 | 1191.34 ± 173.97 | 1229.23 ± 149.79 | 1319.61 ± 157.07 | 8.607 | 0.004 | 0.080 |
CA3a | 395.54 ± 58.86 | 390.07 ± 68.34 | 414.46 ± 56.01 | 433.96 ± 57.62 | 0.479 | 0.490 | 0.005 |
CA4a | 464.64 ± 52.40 | 459.88 ± 64.73 | 489.89 ± 48.30 | 502.93 ± 53.16 | 0.256 | 0.614 | 0.003 |
Molecular layera | 1069.42 ± 112.25 | 1045.28 ± 149.39 | 1107.70 ± 117.61 | 1139.04 ± 124.48 | 6.309 | 0.014 | 0.060 |
GC-ML-DGa | 535.52 ± 62.95 | 524.13 ± 78.41 | 562.64 ± 60.00 | 576.00 ± 67.07 | 0.723 | 0.397 | 0.007 |
aContinuous variable, two-way ANOVA is adopted, and mean ± SD is used for statistical description; the unit of volume is cubic millimeter.
bThere is an interaction between population grouping and BMI grouping after correction by Bonferroni method.
HATA, hippocampal amygdala transition area; CA, cornu ammonis; GC-ML-DG, granule cell layer and molecular layer of the dentate gyrus. The two-way ANOVA was carried out with age, gender, years of education, hypertension, hyperlipidemia, type II diabetes mellitus, whole hippocampus volume, and intracranial volume as covariates.